Regeneron (REGN), Mitsubishi Tanabe Enter Fasinumab Development Agreement; Will Receive $55M Upfront
Tweet Send to a Friend
Regeneron (NASDAQ: REGN) announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
